Combination of nanogel polyethylene glycol-polyethylenimine and 6(hydroxymethyl)-1,4-anthracenedione as an anticancer nanomedicine

Journal of Nanoscience and Nanotechnology

Volumn 8, Issue 5, 2008, Pages 2334-2340

  Ganta, Chanran ^a   Shi, Aibin ^a   Battina, Srinivas K ^a   Pyle, Maria ^a   Rana, Sandeep ^a   Hua, Duy H ^a   Tamura, Masaaki ^a   Troyer, Deryl ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

AQ10; Nanogel PEG PEI; Pan 02 cells

Indexed keywords

HYDROXY METHYL; NANO GELS; NANO MEDICINE; NANO-GELS; POLYETHYLENIMINE (PAH);

ETHYLENE GLYCOL; GLYCOLS; MEDICAL NANOTECHNOLOGY; METHANOL; NANOSTRUCTURED MATERIALS; NUCLEIC ACIDS; OLIGONUCLEOTIDES; POLYETHYLENE GLYCOLS; THERMOPLASTICS;

POLYETHYLENES;

6(HYDROXYMETHYL) 1,4 ANTHRACENEDIONE; 6(HYDROXYMETHYL)-1,4-ANTHRACENEDIONE; ANTHRAQUINONE DERIVATIVE; ANTINEOPLASTIC AGENT; MACROGOL DERIVATIVE; POLYETHYLENEIMINE;

ANIMAL; ARTICLE; CELL PROLIFERATION; GEL; NANOMEDICINE; NEOPLASM; RODENT;

ANIMALS; ANTHRAQUINONES; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; GELS; NANOMEDICINE; NEOPLASMS; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; RODENTIA;

EID: 45849085789     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2008.294     Document Type: Article

References (24)

1. M. Cegnar, J. Kristl, and J. Kos, Expert Opinion on Biological Therapy 5, 1557 (2005).
2. S. V. Vinogradov, Curr. Pharm. Des. 12, 4703 (2006).
3. S. V. Vinogradov, E. V. Batrakova, and A. V. Kabanov, Bioconjug. Chem. 15, 50 (2004).
4. S. V. Vinogradov, T. K. Bronich, and A. V. Kabanov, Adv. Drug Deliv. Rev. 54, 135 (2002).
5. V. N. Uversky, A. V. Kabanov, and Y. L. Lyubchenko, J. Proteome. Res. 5, 2505 (2006).
6. V. P. Torchilin, AAPS. J. 9, E128 (2007).
7. M. Winterhalter and D. D. Lasic, Chem. Phys. Lipids 64, 35 (1993).
8. V. P. Torchilin, Nat. Rev. Drug Discov. 4, 145 (2005).
9. V. P. Torchilin, Immunomethods 4, 244 (1994).
10. J. Wang, D. Mongayt, and V. P. Torchilin, J. Drug Target 13, 73 (2005).
11. A. Elouahabi and J. M. Ruysschaert, Mol. Ther. 11, 336 (2005).
12. A. Kerkis, M. A. Hayashi, T. Yamane, and I. Kerkis, IUBMB. Life 58, 7 (2006).
13. S. J. Sung, S. H. Min, K. Y. Cho, S. Lee, Y. J. Min, Y. I. Yeom, and J. K. Park, Biol. Pharm. Bull. 26, 492 (2003).
14. O. Boussif, F. Lezoualc'h, M. A. Zanta, M. D. Mergny, D. Scherman, B. Demeneix, and J. Behr, PNAS 92, 7297 (1995).
15. D. Goula, C. Benoist, S. Mantera, G. Merlo, G. Levi, and B. A. Demeneix, Gene Ther. 5, 1291 (1998).
16. S. V Vinogradov, A. D. Zeman, E. V. Batrakova, and A. V. Kabanov, J. Control Release 107, 143 (2005).
17. S. V. Vinogradov, E. V Batrakova, S. Li, and A. V. Kabanov, J. Drug Target 12, 517 (2004).
18. W. Dong, G. H. Jin, S. F. Li, Q. M. Sun, D. Y. Ma, and Z. C. Hua, Acta Biochim. Biophys. Sin. (Shanghai) 38, 780 (2006).
19. S. V. Vinogradov, T. K. Bronich, and A. V. Kabanov, Bioconjug. Chem. 9, 805 (1998).
20. P. Erbacher, T. Bettinger, P. Belguise-Valladier, S. Zou, J. L. Coll. J. P. Behr, and J. S. Remy, J. Gene Med. 1, 210 (1999).
21. Y. Wang, E. M. Perchellet, M. M. Ward, K. Lou, D. H. Hua, and J. P. Perchellet, Anticancer Drugs 16, 953 (2005).
22. E. M. Perchellet, Y. Wang, R. L. Weber, B. J. Sperfslage, K. Lou, J. Crossland, D. H. Hua, and J. P. Perchellet, Biochem. Pharmacol. 67, 523 (2004).
23. D. H. Hua, K. Lou, S. K. Battina, H. Zhao, E. M. Perchellet, Y. Wang, and J. R Perchellet, Anticancer Agents Med. Chem. 6, 303 (2006).
24. S. V. Vinogradov, E. Kohli, and A. D. Zeman, Pharm. Res. 23, 920 (2006).